EMA qualifies first artificial intelligence tool to diagnose inflammatory liver disease (MASH) in biopsy samples

EMA’s human medicines committee (CHMP) has issued the first Qualification Opinion (QO) on an innovative development methodology based on artificial intelligence (AI). The tool,…

Leave a Reply

Your email address will not be published. Required fields are marked *